NEUMOLOGÍA PEDIÁTRICA

C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl 22 Neumol Pediatr 2019; 14 (1): 19 - 22 Adenovirus: de la neumonía a la bronquiolitis obliterante Severe Community-Acquired Pneumonia Reveals Conserved Genomes and Capsid Proteins. Front Microbiol. 2018 Jun 5; 9:1180. 9. Xu W, Xu Z, Huang L, Qin EQ, Zhang JL, Zhao P, et al.Transcriptome Sequencing Identifies Novel Immune Response Genes Highly Related to the Severity of Human Adenovirus Type 55 Infection. Front Microbiol. 2019; 10:130. 10. Zhang Y, Bergelson J, Adenovirus Receptors. Journal of Virology 2005: 12125-31. 11. Ginsberg HS. The life and times of adenoviruses. Adv Virus Res. 1999;54:1-13 12. Xie L, Zhang B, Zhou J, Huang H, Zeng S, Liu Q, Xie Z, et al. Human adenovirus load in respiratory tract secretions are predictors for disease severity in children with human adenovirus pneumonia. Virol J. 2018 Aug 7; 15(1): 123. 13. Tran TTP, Eichholz K, Amelio P, Moyer C, Nemerow GR, Perreau M, et al. Humoral immune response to adenovirus induce tolerogenic bystander dendritic cells that promote generation of regulatory T cells. PLoS Pathog. 2018 Aug 20;14 (8). e1007127. doi: 10.1371/journal.ppat.1007127 14. Shen CF, Wang SM, Ho TS, Liu CC. Clinical features of community acquired adenovirus pneumonia during the 2011 community outbreak in Southern Taiwan: role of host immune response. BMC Infect Dis. 2017 Mar 7;17 (1):196. 15. Mauad T, van Schadewijk A, Schrumpf J, Hack CE, Fernezlian S, Garippo AL, et al. São Paulo BO Study Group Lymphocytic inflammation in childhood bronchiolitis obliterans. Pediatr Pulmonol. 2004 Sep;38 (3):233-9. 16. Fu Y, Tang Z, Ye Z, Mo S, Tian X, Ni K, et al. Human adenovirus type 7 infection causes a more severe disease than type 3. BMC Infect Dis. 2019 Jan 9; 19(1):36. 17. Rosewich M, Zissler U, Kheiri T, et al. Airway inflammation in children and adolescents with bronchiolitis Obliterans. Cytokine. 2015;73: 156–162. 18. Mauad T, Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol 2002;33 (6):466–74. 19. Rodríguez-Núñez I, Zenteno D. Rehabilitación respiratoria en niños y adolescentes con bronquiolitis obliterante post infecciosa Neumol Pediatr 2017; 12 (4): 175 - 181 20. Mattiello R, Mallol J, Fischer GB, Mocelin HT, Rueda B, Sarria EE. Pulmonary function in children and adolescents with postinfectious bronchiolitis obliterans. J Bras Pneumol 2010; 36 (4):451–7. 21. Castro J, Daszenies C, Garcia M, Meyer R, González R. Adenovirus Pneumonia in Infants and Factors for Developing Bronchiolitis Obliterans. Pediatric Pulmonology 2006; 41:947-953. 22. Colom AJ, Teper AM, Vollmer WM, Diette GB. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 2006;61(6):503–6. 23. Murtagh P, Giubergia V, Viale D, et al. Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronchiolitis obliterans and mortality. Pediatr Pulmonol 2009;44(5):450-6. 24. Teper AM, Marcos CY, Theiler G, Colom AJ, Fainboim L. Association between HLA and the incidence of Bronchiolitis Obliterans in Argentina. Am J Respir Crit Care Med 2004; 169 (Suppl.): A 382. 25. Palomino MA, Larrañaga C, Avendaño LF. Hospital-acquired adenovirus 7h infantile respiratory infection in Chile. Pediatr Infect Dis J 2000; 19: 527-531. 26. Rodríguez A, Campaña A, Bustos D, Cifuentes P, Clement P, Cofré F, Acuña M. Infección por adenovirus en el hospital de niños Roberto del Río, 2016 Rev Ped Elec 2017; 14: ISSN 0718-0918 27. Sly PD, Soto-Quiros ME, Landau LI, Hudson I, Newton- John H. Factors predisposing to abnormal pulmonary function after adenovirus type 7 pneumonia. Arch Dis Child. 1984;59:935-9. 28. Kusznierz G, Cociglio R, Pierini J, Malatini M, Walker A, Millán A. Infección respiratoria aguda por adenovirus en niños hospitalizados de Santa Fe. Arch. argent. pediatr.2007; 105 (2): 216-220. 29. Choudhry A, Mathena J, Albano JD, Yacovone M, Collins L. Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits. Vaccine. 2016 Aug 31; 34(38):4558-4564. 30. Larrañaga C, Avendaño LF, Gaggero A, Suárez M, Montaldo G, Palomino MA y Díaz A. Diagnóstico de infección por adenovirus y virus respiratorio sincicial en lactantes: comparación entre aislamiento e inmunofluorescencia indirecta. Rev Chile Infect 1990; 7 (3): 167-171. 31. Cui X, Wen L, Wu Z, Liu N, Yang C, Liu W, et al. Human adenovirus type 7 infection associated with severe and fatal acute lower respiratory illness and nosocomial transmission. J Clin Microbiol. 2015 Feb; 53(2):746-9. 32. Takahashi I, Takahashi T, Tsuchida S, Mikami T, Saito H, Hatazawa C, Takada G. Tohoku. Pulse methylprednisolone therapy in type 3 adenovirus pneumonia with hypercytokinemia. J Exp Med. 2006; 209(1):69-73 33. Wang X, Liu C, Wang M, Zhang YI, Li H, Liu G. .Clinical features of post-infectious bronchiolitis obliterans in children undergoing long-term azithromycin treatment. Exp Ther Med. 2015; 9(6):2379-2383. 34. Ganapathi L, Arnold A, Jones S, Patterson A, Graham D, Harper M, Levy O. Use of cidofovir in pediatric patients with adenovirus infection.Version 2. F1000 Res. 2016; 5:758. 35. Joseph P. Lynch III, MD Adriana E. Kajon, Ph Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention. Semin Respir Crit Care Med 2016;37:586–602.